메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 26, Issue 10, 2008, Pages 1771-1772
Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer
Author keywords

[No Author keywords available]
Indexed keywords

CA 125 ANTIGEN; PLATINUM; TAXANE DERIVATIVE; TUMOR MARKER;
EID: 43249085533     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.7594     Document Type: Letter
Times cited : (5)
References (6)
  • 1
    • 37849025830 scopus 로고    scopus 로고
    • Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A Gynecologic Oncology Group study
    • Winter WR, Maxwell G, Tian C, et al: Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 26:83-89, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 83-89
    • Winter, W.R.1    Maxwell, G.2    Tian, C.3
  • 2
    • 33747871968 scopus 로고    scopus 로고
    • The prognostic significance of the CA125 nadir in patients that achieve a CA125 response
    • suppl; abstr 5001, 9s
    • Crawford SM, Paul J, Reed NS, et al: The prognostic significance of the CA125 nadir in patients that achieve a CA125 response. J Clin Oncol 23:9s, 2004 (suppl; abstr 5001)
    • (2004) J Clin Oncol , vol.23
    • Crawford, S.M.1    Paul, J.2    Reed, N.S.3
  • 3
    • 12344319318 scopus 로고    scopus 로고
    • Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?
    • Crawford SM, Peace J: Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Ann Oncol 16:47-50, 2005
    • (2005) Ann Oncol , vol.16 , pp. 47-50
    • Crawford, S.M.1    Peace, J.2
  • 4
    • 33645451136 scopus 로고    scopus 로고
    • Pretreatment CA-125 and risk of relapse in advanced ovarian cancer
    • Markman M, Liu PY, Rothenberg ML, et al: Pretreatment CA-125 and risk of relapse in advanced ovarian cancer. J Clin Oncol 24:1454-1458, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 1454-1458
    • Markman, M.1    Liu, P.Y.2    Rothenberg, M.L.3
  • 5
    • 33846010186 scopus 로고    scopus 로고
    • CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy
    • Juretzka MM, Barakat RR, Chi DS, et al: CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Gynecol Oncol 104:176-180, 2007
    • (2007) Gynecol Oncol , vol.104 , pp. 176-180
    • Juretzka, M.M.1    Barakat, R.R.2    Chi, D.S.3
  • 6
    • 38849091947 scopus 로고    scopus 로고
    • Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer
    • Prat A, Parera M, Peralta S, et al: Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer. Ann Oncol 19:327-331, 2008
    • (2008) Ann Oncol , vol.19 , pp. 327-331
    • Prat, A.1    Parera, M.2    Peralta, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.